Monoclonal antibody manufacturing in transgenic plants — myths and realities
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 13 (6) , 630-635
- https://doi.org/10.1016/s0958-1669(02)00351-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Plantibodies: applications, advantages and bottlenecksCurrent Opinion in Biotechnology, 2002
- From green plants to industrial enzymesEnzyme and Microbial Technology, 2002
- Production of secretory IgA antibodies in plantsBiomolecular Engineering, 2001
- Transgenic plants as protein factoriesCurrent Opinion in Biotechnology, 2001
- Producing proteins in transgenic plants and animalsCurrent Opinion in Biotechnology, 2001
- Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plantsTrends in Plant Science, 2001
- Plant-based vaccines: unique advantagesVaccine, 2001
- Galactose-extended glycans of antibodies produced by transgenic plantsProceedings of the National Academy of Sciences, 2001
- A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in miceTransgenic Research, 2000
- Molecular Farming of Recombinant Antibodies in PlantsBiological Chemistry, 1999